Incyte Corporation
NASDAQIncyte Corporation heads into the final stretch before its July 28 Q2 print with an unusual split in signals — short sellers are covering at the fastest pace in months, yet options traders are hedging more than they have all spring. The short-covering story is the clearest near-term development. SI as a percentage of free float has dropped from a peak of 7.19% on April 28 to 6.38%…
Snapshot as of 22 Jun 2026
Incyte Corporation heads into the final stretch before its July 28 Q2 print with an unusual split in signals — short sellers are covering at the fastest pace in months, yet options traders are hedging more than they…
Incyte Corporation reported Q1 2026 results on April 28, and the market reacted better than bears expected — yet short sellers are still adding to positions, and options traders are hedging at an intensity not seen in…
Incyte Corporation trades at $96.74, up 6.6% over the past month despite a modest 0.4% dip this week. The biotech firm reports Q1 2026 results on April 28. Short interest sits at 5.79% of float. That's low for biotech.…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for INCY — free to start on ORTEX.
Sign up for free →Open INCY on ORTEX